inclusion criteria: 1. capable of understanding the written informed consent, provides signed written informed consent, and agrees to comply with protocol requirements. 2. male or female aged ≥18 years. 3. must have a symptomatic household contact ("index case") with rapid antigen/point of-care or rt-pcr-confirmed sars-cov-2 infection and onset of symptoms in the household contact within 5 days prior to screening. 4. participants of non-childbearing potential. non-childbearing potential is defined as surgically sterile (history of bilateral tubal ligation, bilateral oophorectomy, hysterectomy, or vasectomy) or postmenopausal (amenorrhea for at least 12 months prior to screening without an alternative medical cause).

inclusion criteria: 1. capable of understanding the written informed consent, provides signed written informed consent, and agrees to comply with protocol requirements. 2. male or female aged ≥18 years. 3. must have a symptomatic household contact ("index case") with rapid antigen/point of-care or rt-pcr-confirmed sars-cov-2 infection and onset of symptoms in the household contact within 5 days prior to screening. 4. participants of non-childbearing potential. non-childbearing potential is defined as surgically sterile (history of bilateral tubal ligation, bilateral oophorectomy, hysterectomy, or vasectomy) or postmenopausal (amenorrhea for at least 12 months prior to screening without an alternative medical cause).

inclusion criteria: capable of understanding the written informed consent, provides signed written informed consent, and agrees to comply with protocol requirements. male or female aged ≥18 years. must have a symptomatic household contact ("index case") with rapid antigen/point of-care or rt-pcr-confirmed sars-cov-2 infection and onset of symptoms in the household contact within 5 days prior to screening. participants of non-childbearing potential. non-childbearing potential is defined as surgically sterile (history of bilateral tubal ligation, bilateral oophorectomy, hysterectomy, or vasectomy) or postmenopausal (amenorrhea for at least 12 months prior to screening without an alternative medical cause).

inclusion criteria: capable of understanding the written informed consent, provides signed written informed consent, and agrees to comply with protocol requirements. male or female aged ≥18 years. must have a symptomatic household contact ("index case") with rapid antigen/point of-care or rt-pcr-confirmed sars-cov-2 infection and onset of symptoms in the household contact within 5 days prior to screening. participants of non-childbearing potential. non-childbearing potential is defined as surgically sterile (history of bilateral tubal ligation, bilateral oophorectomy, hysterectomy, or vasectomy) or postmenopausal (amenorrhea for at least 12 months prior to screening without an alternative medical cause).

inclusion criteria: 1. capable of understanding the written informed consent, provides signed written informed consent, and agrees to comply with protocol requirements. 2. male or female aged ≥18 years. 3. must have a symptomatic household contact ("index case") with rapid antigen/point of-care or rt-pcr-confirmed sars-cov-2 infection and onset of symptoms in the household contact within 5 days prior to screening. 4. participants of non-childbearing potential. non-childbearing potential is defined as surgically sterile (history of bilateral tubal ligation, bilateral oophorectomy, hysterectomy, or vasectomy) or postmenopausal (amenorrhea for at least 12 months prior to screening without an alternative medical cause).

inclusion criteria: 1. capable of understanding the written informed consent, provides signed written informed consent, and agrees to comply with protocol requirements. 2. male or female aged ≥18 years. 3. must have a symptomatic household contact ("index case") with rapid antigen/point of-care or rt-pcr-confirmed sars-cov-2 infection and onset of symptoms in the household contact within 5 days prior to screening. 4. participants of non-childbearing potential. non-childbearing potential is defined as surgically sterile (history of bilateral tubal ligation, bilateral oophorectomy, hysterectomy, or vasectomy) or postmenopausal (amenorrhea for at least 12 months prior to screening without an alternative medical cause).